HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Leandro Provinciali Selected Research

Leandro Provinciali Research Topics

Disease

5	Stroke (Strokes) 01/2013 - 09/2007
4	Seizures (Seizure) 04/2015 - 02/2007
4	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 12/2013
4	Parkinson Disease (Parkinson's Disease) 04/2009 - 12/2004
3	Dementia (Dementias) 01/2015 - 06/2012
2	Relapsing-Remitting Multiple Sclerosis 11/2015 - 09/2008
2	Migraine Disorders (Migraine) 04/2015 - 11/2005
2	Multiple Sclerosis 01/2014 - 12/2013
2	Sialorrhea 04/2009 - 05/2006
1	Disease Progression 11/2015
1	Partial Epilepsies (Epilepsy, Partial) 09/2015
1	Renal Insufficiency (Renal Failure) 07/2015
1	Neoplasms (Cancer) 07/2015
1	Heart Failure 07/2015
1	Nervous System Diseases (Neurological Disorders) 07/2015
1	Granuloma 04/2015
1	Pain (Aches) 04/2015
1	Inflammation 01/2015
1	Venous Insufficiency 12/2013
1	Frontotemporal Lobar Degeneration (Semantic Dementia) 12/2013
1	Insulin Resistance 05/2013
1	Weight Loss (Weight Reduction) 02/2013
1	Diabetes Mellitus 04/2008
1	Hypertension (High Blood Pressure) 04/2008
1	Carotid Artery Diseases 04/2008
1	Ischemia 01/2008
1	Glioma (Gliomas) 02/2007
1	Brain Neoplasms (Brain Tumor) 02/2007
1	Demyelinating Diseases (Demyelinating Disease) 05/2006
1	Tremor (Tremors) 05/2005
1	Parkinsonian Disorders (Parkinsonism) 12/2004
1	Dyskinesias (Dyskinesia) 12/2004

Drug/Important Bio-Agent (IBA)

3	Aryldialkylphosphatase (Paraoxonase)IBA 01/2015 - 01/2008
2	Platelet Activating FactorIBA 01/2015 - 01/2015
2	Lipoproteins (Lipoprotein)IBA 01/2015 - 01/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2014 - 12/2013
2	Amyloid (Amyloid Fibrils)IBA 12/2013 - 05/2013
2	Biological Markers (Surrogate Marker)IBA 12/2011 - 01/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011 - 09/2007
2	Levodopa (L Dopa)FDA LinkGeneric 05/2005 - 12/2004
1	fingolimod (FTY720)FDA Link 11/2015
1	CholesterolIBA 04/2015
1	lacosamide FDA Link 04/2015
1	salicylhydroxamic acid (SHAM)IBA 04/2015
1	First StepIBA 01/2015
1	oxidized low density lipoproteinIBA 01/2015
1	HormonesIBA 07/2014
1	Progesterone FDA LinkGeneric 07/2014
1	Staphylococcal Protein A (A, Protein)IBA 01/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Interferon-betaIBA 01/2014
1	ApolipoproteinsIBA 01/2014
1	AntibodiesIBA 01/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2013
1	Serine Proteases (Serine Protease)IBA 12/2013
1	Insulin (Novolin)FDA Link 05/2013
1	Angiotensin Receptor AntagonistsIBA 01/2013
1	glucuronyl glucosamine glycan sulfate (Vessel)IBA 06/2012
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2011
1	batrachotoxinin A 20-alpha-benzoateIBA 04/2009
1	rimabotulinumtoxinB FDA Link 04/2009
1	natalizumab (Tysabri)FDA Link 09/2008
1	Adenosine Triphosphatases (ATPase)IBA 04/2008
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2008
1	1- (4- (trimethylamino)phenyl)- 6- phenylhexa- 1,3,5- trieneIBA 04/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008
1	ZincIBA 04/2008
1	Free RadicalsIBA 01/2008
1	3-nitrotyrosineIBA 09/2007
1	Peroxynitrous Acid (Peroxynitrite)IBA 09/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2007
1	oxcarbazepine (Trileptal)FDA LinkGeneric 02/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	Type A Botulinum Toxins (Botulinum A Toxin)FDA Link 05/2006
1	topiramate (Topamax)FDA LinkGeneric 11/2005
1	Valproic Acid (Valproate, Semisodium)FDA LinkGeneric 11/2005
1	pramipexol (pramipexole)FDA LinkGeneric 05/2005

Therapy/Procedure

2	Injections 04/2009 - 05/2006
1	Electrodes (Electrode) 09/2015
1	Palliative Care (Palliative Medicine) 07/2015
1	Activities of Daily Living (ADL) 12/2014
1	Angioplasty (Angioplasty, Transluminal) 12/2013
1	Drug Therapy (Chemotherapy) 02/2013
1	Deep Brain Stimulation 12/2004